Evidence map›Paper›PMID 39715490›Full record

ArticleJournal of neuropathology and experimental neurology2025

An analysis of RNA quality metrics in human brain tissue.

Jiahe Tian, Tiffany G Lam, Sophie K Ross, Benjamin Ciener, Sandra Leskinen, Sharanya Sivakumar, David A Bennett, Vilas Menon, Guy M McKhann, Alexi Runnels and 1 more

Abstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Transcriptomic Convergence in Autism Spectrum Disorder: Synaptic, Immune-Glial and RNA-Regulatory Axes in the Human Cerebral Cortex.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jiahe TianDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
Tiffany G LamDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
Sophie K RossDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
Benjamin CienerDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
Sandra LeskinenDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
Sharanya SivakumarDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, United States.
Vilas MenonTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, United States.
Guy M McKhannDepartment of Neurosurgery, Columbia University Irving Medical Center, New York, NY, United States.
Alexi RunnelsNew York Genome Center, New York, NY, United States.
Andrew F TeichDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.ORCID 0000-0002-1916-8490

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)U24AG056270 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gary Wayne Beecham, TATIANA M. FOROUD · 2017 to 2026
$31.4M
Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PHILIP L DE JAGER · 2020 to 2026
$30.1M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targetsU01AG061356 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2018 to 2022
$13.7M
Pathway discovery, validation and compound identification for Alzheimer's disease - SupplementU01AG046152 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2013 to 2017
$13.6M
Epidemiological and Genetic Investigations of Blood-Based Biomarkers for Alzheimer's Disease in the Multiethnic, Washington Heights, Inwood, Columbia Aging Project (WHICAP)R01AG072474 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BRICKMAN, ADAM M, MANLY, JENNIFER JAIE · 2021 to 2025
$13.3M
An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patientsR01AG073360 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MCKHANN, GUY M, TEICH, ANDREW FRANKLIN · 2021 to 2025
$4.2M
An integrative analysis of DNA methylation, transcriptomic changes, and cognitive dysfunction in Alzheimer's diseaseK76AG054868 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TEICH, ANDREW FRANKLIN · 2016 to 2018
$633k
A systems approach to DNA methylation, gene expression, and cognitive dysfunction in Alzheimer's diseaseK08AG049938 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TEICH, ANDREW FRANKLIN · 2015 to 2016
$254k
NIA NIH HHS K08 AG049938NIA NIH HHS K76 AG054868NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG066462NIA NIH HHS P30 AG072975NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG072474NIA NIH HHS R01 AG073360NIA NIH HHS U01 AG046152NIA NIH HHS U01 AG061356NIA NIH HHS U24 AG056270NIH HHS K08AG049938Thompson Family Foundation
6 · The paper itself

Abstract

Human brain tissue studies have used a range of metrics to assess RNA quality but there are few large-scale cross-comparisons of presequencing quality metrics with RNA-seq quality. We analyzed how postmortem interval (PMI) and RNA integrity number (RIN) before RNA-seq relate to RNA quality after sequencing (percent of counts in top 10 genes [PTT], 5' bias, and 3' bias), and with individual gene counts across the transcriptome. We analyzed 4 human cerebrocortical tissue sets (1 surgical, 3 autopsy), sequenced with varying protocols. Postmortem interval and RIN had a low inverse correlation (down to r = -0.258, P < .001 across the autopsy cohorts); both PMI and RIN showed consistent and opposing correlations with PTT (up to r = 0.215, P < .001 for PMI and down to r = -0.677, P < .001 for RIN across the autopsy cohorts). Unlike PMI, RIN showed consistent correlations with measurements of 3' and 5' bias in autopsies (r = -0.366, P < .001 with 3' bias). RNA integrity number correlated with 3933 genes across the 4 datasets vs 138 genes for PMI. Neuronal and immune response genes correlated positively and negatively with RIN, respectively. Thus, different gene sets have divergent relationships with RIN. These analyses suggest that conventional metrics of RNA quality have varying values and that PMI has an overall modest effect on RNA quality.

Indexed as

BrainRNAAutopsyFemaleHumansMaleMiddle AgedPostmortem ChangesSequence Analysis, RNATranscriptomeRNApostmortem interval (PMI)RNA integrity number (RIN)RNA-seq

Identifiers

PMID39715490
PMCPMC11842900

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.